Peng, L.; Li, Y.; Yao, S.; Gaedcke, J.; Baart, V.M.; Sier, C.F.M.; Neesse, A.; Ellenrieder, V.; Bohnenberger, H.; Fuchs, F.;
et al. Urokinase-Type Plasminogen Activator Receptor (uPAR) Cooperates with Mutated KRAS in Regulating Cellular Plasticity and Gemcitabine Response in Pancreatic Adenocarcinomas. Cancers 2023, 15, 1587.
https://doi.org/10.3390/cancers15051587
AMA Style
Peng L, Li Y, Yao S, Gaedcke J, Baart VM, Sier CFM, Neesse A, Ellenrieder V, Bohnenberger H, Fuchs F,
et al. Urokinase-Type Plasminogen Activator Receptor (uPAR) Cooperates with Mutated KRAS in Regulating Cellular Plasticity and Gemcitabine Response in Pancreatic Adenocarcinomas. Cancers. 2023; 15(5):1587.
https://doi.org/10.3390/cancers15051587
Chicago/Turabian Style
Peng, Luogen, Yuchan Li, Sha Yao, Jochen Gaedcke, Victor M. Baart, Cornelis F. M. Sier, Albrecht Neesse, Volker Ellenrieder, Hanibal Bohnenberger, Frieder Fuchs,
and et al. 2023. "Urokinase-Type Plasminogen Activator Receptor (uPAR) Cooperates with Mutated KRAS in Regulating Cellular Plasticity and Gemcitabine Response in Pancreatic Adenocarcinomas" Cancers 15, no. 5: 1587.
https://doi.org/10.3390/cancers15051587
APA Style
Peng, L., Li, Y., Yao, S., Gaedcke, J., Baart, V. M., Sier, C. F. M., Neesse, A., Ellenrieder, V., Bohnenberger, H., Fuchs, F., Kitz, J., Ströbel, P., & Küffer, S.
(2023). Urokinase-Type Plasminogen Activator Receptor (uPAR) Cooperates with Mutated KRAS in Regulating Cellular Plasticity and Gemcitabine Response in Pancreatic Adenocarcinomas. Cancers, 15(5), 1587.
https://doi.org/10.3390/cancers15051587
